Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective.
about
Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failureArrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and ManagementDifferential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita heartsAssociations between Interleukin-31 Gene Polymorphisms and Dilated Cardiomyopathy in a Chinese Population.Pro/Anti-inflammatory cytokine imbalance in postischemic left ventricular remodelingPlasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarctionCirculating annexin A5 levels after atrial switch for transposition of the great arteries: relationship with ventricular deformation and geometryIncrease of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failureCellular remodeling in heart failure disrupts K(ATP) channel-dependent stress toleranceEmerging therapeutic targets in chronic heart failure: part II.Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome.The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis.Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.Changes in the myocardial interstitium and contribution to the progression of heart failure.Increased expression of 78 kD glucose-regulated protein promotes cardiomyocyte apoptosis in a rat model of liver cirrhosis.Toxicity of infliximab in the course of treatment of Crohn's disease.Endogenous angiogenesis inhibitors prevent adaptive capillary growth in left ventricular pressure overload hypertrophy.Effects of a novel bradykinin B1 receptor antagonist and angiotensin II receptor blockade on experimental myocardial infarction in rats.An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model.RAGE and modulation of ischemic injury in the diabetic myocardiumPredictors and prevention of diabetic cardiomyopathy.Tissue-Engineering for the Study of Cardiac Biomechanics.Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486.Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.Peripartum cardiomyopathy: review of the literature.Mechanisms of sex differences in TNFR2-mediated cardioprotection.MMP-9 signaling in the left ventricle following myocardial infarction.Acute heart failure: patient characteristics and pathophysiology.Inhibition of ubiquitin protein expression and 20S proteasome activity by irbesartan prevents post-infarction ventricular remodeling and decreases TNF-α generationCompartmentation of membrane processes and nucleotide dynamics in diffusion-restricted cardiac cell microenvironment.Myocyte signalling in leucocyte recruitment to the heart.The impact of arteriovenous fistulae on the myocardium: the impact of creation and ligation in the transplant era.Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.Cardiac fibroblast physiology and pathology.Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure.p21(WAF1/Cip1/Sdi1) knockout mice respond to doxorubicin with reduced cardiotoxicityMatrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3.Hypertension in African Americans with heart failure: progression from hypertrophy to dilatation; perhaps not.Influence of therapeutic hypothermia on matrix metalloproteinase activity after traumatic brain injury in rats.
P2860
Q24684669-7B9DB19E-87AD-4359-88B1-E04F59A360B2Q28268244-E9DDB59F-CEFC-438B-A6A2-4D72ED1B5663Q28293366-854415BD-CE6A-4D98-966B-27C048B203EBQ33721279-3788BBB2-FC92-43A7-B234-AE0352E835DFQ33836204-01E8BB9C-9CC3-4FB1-8CC0-67A56DD6A026Q34045555-84486FF9-829E-43F3-9498-FC17EBECB1C5Q34533063-B2F826AB-2D2F-4A31-B6EE-5DD0D12F6F3FQ34748917-549BCD2A-6ABF-45EC-A936-206CDACB0820Q34986013-A0AA8FA9-94A4-4B3B-BEE5-18AAB7F0352DQ35056026-56F4A36E-0AE3-4618-A368-BD1BBB154148Q35115060-05B00519-606A-424A-8E0E-A81435D9A524Q35170453-C77BCE47-6F15-41BB-8E57-2033C585A4B0Q35467456-7166B963-C427-4968-A3B2-6E6F1E591E2BQ35582221-0FC08246-3F93-496F-8067-AE57603D74C9Q36095234-22EC20D7-769C-4216-92CB-3BA261BFBC68Q36349717-F496BA14-7198-461C-9FEF-659310395FFEQ36350701-8AFCC34F-2F98-4CAE-8D74-9CF91CCA4AB4Q36453772-1DA44D02-0DFB-420D-90B5-69CC20D99D1EQ36725312-0CEDE043-78B0-48EF-A4A7-BCD414985368Q36756482-BC1556CC-6F60-433E-B44E-D825A2FC97F5Q36776922-5ADED5C2-8073-4845-ADA0-3548EA82B21DQ36836302-EA701C6E-7FCF-43D3-9831-40BB701AFC11Q36865075-53AE0E09-2611-4D14-821D-4C670F6EE73AQ36915712-1F4F03B2-462F-40F1-830F-DCEFD3AF3BD7Q36982631-F1071A75-6B88-46B3-8914-FAC30ED5B6D6Q37126935-6180A621-225B-4890-A5F6-34D9059E22F4Q37139613-61180051-AB1C-490F-96DE-143C851A5EA9Q37297364-B969D7ED-E702-4199-8A0D-C464B1843674Q37565533-27D78378-7BAA-4406-B605-7710A0093583Q37894285-1811FECC-B513-4886-95A0-EF2981DE0177Q38185647-9229563E-6822-4C87-9EA9-336714639F92Q38255386-7B2769B6-0A73-4117-AFE9-34815903F334Q38260198-C81961E1-F8AB-478F-8124-9D0D4347473FQ38423895-E12FE106-3F7D-4F33-A99C-034839B8ECF6Q38486305-E1C67EAC-788F-4121-8A5B-5FA58F6B4846Q38833346-B456B8D1-8DBC-4A7F-8BE4-F6DA6AF2790AQ41929473-F26E1C5C-D6BC-4914-9A27-7D32BF5CC057Q44185566-D9E2D716-1055-47FE-A808-DA680232AEFDQ46155867-69B771AD-198C-49F8-8FAA-5904851D0DC0Q48852577-205FCEAC-72B5-43B4-A12D-0BD789705048
P2860
Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@ast
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@en
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@nl
type
label
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@ast
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@en
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@nl
prefLabel
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@ast
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@en
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@nl
P2093
P1476
Tumor necrosis factor-alpha an ...... ailure: a current perspective.
@en
P2093
Biykem Bozkurt
Francis G Spinale
Himali Gunasinghe
William S Bradham
P304
P356
10.1016/S0008-6363(01)00503-X
P577
2002-03-01T00:00:00Z